AGEN (STOCKS)
Agenus Inc.
$7.030000
+0.130000 (+1.88%)
Prev close: $6.900000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Garo H. Armen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $316.04M
- Employees
- 316
- P/E (TTM)
- 2.60
- P/B (TTM)
- -1.48
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.01 | $0.05 | -0.0610 | -119.61% |
|
Mar 2026 (Q1)
|
$0.00 | $2.14 | -2.1420 | -100.00% |
|
Dec 2025 (Q4)
|
$-0.31 | $-1.07 | +0.7634 | +71.05% |
|
Sep 2025 (Q3)
|
$1.94 | $2.02 | -0.0796 | -3.94% |
Financial Statements
| Revenues | $132.69M |
| Benefits Costs and Expenses | $40.76M |
| Cost Of Revenue | $642.00K |
| Costs And Expenses | $53.05M |
| Nonoperating Income/Loss | -$1.30M |
| Operating Expenses | $95.85M |
| Depreciation and Amortization | $4.73M |
| Research and Development | $57.69M |
| Other Operating Expenses | $36.98M |
| Operating Income/Loss | $36.20M |
| Income/Loss From Continuing Operations After Tax | $91.94M |
| Income/Loss From Continuing Operations Before Tax | $91.94M |
| Income/Loss From Equity Method Investments | -$25.17M |
| Net Income/Loss | $91.94M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$74.00K |
| Net Income/Loss Attributable To Parent | $91.83M |
| Net Income/Loss Available To Common Stockholders, Basic | $91.80M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.60 |
| Diluted Earnings Per Share | $2.58 |
| Basic Average Shares | 112,715,000 |
| Diluted Average Shares | 113,951,000 |
| Assets | $172.69M |
| Current Assets | $78.81M |
| Prepaid Expenses | $2.85M |
| Other Current Assets | $75.96M |
| Noncurrent Assets | $93.88M |
| Fixed Assets | $14.32M |
| Intangible Assets | $2.88M |
| Other Non-current Assets | $76.68M |
| Liabilities | $378.54M |
| Current Liabilities | $231.82M |
| Accounts Payable | $58.98M |
| Other Current Liabilities | $172.84M |
| Noncurrent Liabilities | $146.72M |
| Long-term Debt | $30.07M |
| Other Non-current Liabilities | $116.65M |
| Equity | -$205.85M |
| Equity Attributable To Noncontrolling Interest | -$6.78M |
| Equity Attributable To Parent | -$199.08M |
| Liabilities And Equity | $172.69M |
| Net Cash Flow From Operating Activities | -$98.50M |
| Net Cash Flow From Operating Activities, Continuing | -$98.50M |
| Net Cash Flow From Investing Activities | $70.08M |
| Net Cash Flow From Investing Activities, Continuing | $70.08M |
| Net Cash Flow From Financing Activities | $35.75M |
| Net Cash Flow From Financing Activities, Continuing | $35.75M |
| Net Cash Flow | $7.32M |
| Net Cash Flow, Continuing | $7.32M |
| Other Comprehensive Income/Loss | $1.05M |